Figure 4.
pTauSer395/Ser404 immunoreactivity following HD-LRRK2G2019S injections in the putamen: pTauSer395/Ser404 immunoreactivity in the internal capsule in (A) an intact animal (control), contralateral hemisphere, and injected hemisphere. Scale bar, 100 μm. (B) Quantification of pTauSer395/Ser404 immunoreactivity by optic densitometry. *p ≤ 0.05 (student’s t-test).